FindTrial
Sign In

Peri-operative Xuebijing reduce the cardio-pulmonary injury after cardiopulmonary bypass

Peri-operative Xuebijing reduce the cardio-pulmonary injury after cardiopulmonary bypass

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-TRC-14004628
Enrollment
Unknown
Registered
2014-05-12
Start date
2014-06-30
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

cardio-pulmonary injury after CPB

Interventions

Control group:saline injection
Xuebijing group:saline injection

Sponsors

The Second Affiliated Hospital of Harbin Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
25 Years to 65 Years

Inclusion criteria

Inclusion criteria: 50 patients with CPB, ASA II-III, heart function II-III, aged 25 to 65 years old.

Exclusion criteria

Exclusion criteria: Severe lung disease or lung dysfunction, patients with immune dysfunction,toxemia, pleural effusion, lung infection, hypoproteinemia, patients with hepatic, renal or coagulation disorder, COPD and asthma were excluded.

Design outcomes

Primary

MeasureTime frame
CI;SV;SVR;elastase;concentration of protein;arterial blood analysis;troponin;myoglobulin;CKM;—

Secondary

MeasureTime frame
TNF-a;IL-1;IL-6;IL-6;IL-10;ICAM-1;CR;—

Contacts

Public ContactWei Gao
gaowei20055@126.com+86 13836172191

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Mar 6, 2026